Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

FDA recall notice · announced April 10, 2013 · Dr. Reddy's Laboratories

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

Reason for recall

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Notes

Distribution: Nationwide and Puerto Rico.
Lot/code information: Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.
Quantity: 117,546 bottles
Status: Terminated
Products in this recall event:
- Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15. (D-238-2013)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.